Marder, Stephen R.

Mapping genomic loci implicates genes and synaptic biology in schizophrenia

Trubetskoy, V., Pardiñas, A. F., Qi, T., Panagiotaropoulou, G., Awasthi, S., Bigdeli, T. B., Bryois, J., Chen, C.-Y., Dennison, C. A., Hall, L. S., et al. (2022) · Nature

Schizophrenia research and treatmentGenetic Associations and Epidemiology

Cited by 2,964

The MATRICS Consensus Cognitive Battery, part 1: test selection, reliability, and validity

Nuechterlein, K. H., Green, M. F., Kern, R. S., Baade, L. E., Barch, D. M., Cohen, J. D., Essock, S., Fenton, W. S., Frese, F. J., Gold, J. M., et al. (2008) · American Journal of Psychiatry

Schizophrenia research and treatmentPsychological Testing and Assessment

Cited by 2,342

Rare coding variants in ten genes confer substantial risk for schizophrenia

Singh, T., Poterba, T., Curtis, D., Akil, H., Al Eissa, M., Barchas, J. D., Bass, N., Bigdeli, T. B., Breen, G., Bromet, E. J., et al. (2022) · Nature

Schizophrenia research and treatmentGenetic Associations and Epidemiology

Cited by 983

Approaching a consensus cognitive battery for clinical trials in schizophrenia: The NIMH-MATRICS conference to select cognitive domains and test criteria

Green, M. F., Nuechterlein, K. H., Gold, J. M., Barch, D. M., Cohen, J., Essock, S., Fenton, W. S., Frese, F., Goldberg, T. E., Heaton, R. K., et al. (2004) · Biological Psychiatry

Schizophrenia research and treatmentPsychological Testing and Assessment

Cited by 919

The brief negative symptom scale: Psychometric properties

Kirkpatrick, B., Strauss, G. P., Nguyen, L., Fischer, B. A., Daniel, D. G., Cienfuegos, A., & Marder, S. R. (2011) · Schizophrenia Bulletin

Schizophrenia research and treatmentPsychological Testing and Assessment

Cited by 895

The MATRICS Consensus Cognitive Battery, part 2: co-norming and standardization

Kern, R. S., Nuechterlein, K. H., Green, M. F., Baade, L. E., Fenton, W. S., Gold, J. M., Keefe, R. S. E., Mesholam-Gately, R., Mintz, J., Seidman, L. J., et al. (2008) · American Journal of Psychiatry

Schizophrenia research and treatmentPsychological Testing and Assessment

Cited by 744

The current conceptualization of negative symptoms in schizophrenia

Marder, S. R., & Galderisi, S. (2017) · World Psychiatry

Schizophrenia research and treatmentMental Health and Psychiatry

Cited by 537

The Cognitive and Negative Symptoms in Schizophrenia Trial (CONSIST): the efficacy of glutamatergic agents for negative symptoms and cognitive impairments

Buchanan, R. W., Javitt, D. C., Marder, S. R., Schooler, N. R., Gold, J. M., McMahon, R. P., Heresco-Levy, U., & Carpenter, W. T. (2007) · American Journal of Psychiatry

Schizophrenia research and treatmentAmino Acid Enzymes and Metabolism

Cited by 419

The neurobiology of treatment-resistant schizophrenia: paths to antipsychotic resistance and a roadmap for future research

Potkin, S. G., Kane, J. M., Correll, C. U., Lindenmayer, J.-P., Agid, O., Marder, S. R., Olfson, M., & Howes, O. D. (2020) · npj Schizophrenia

Schizophrenia research and treatmentNeurotransmitter Receptor Influence on Behavior

Cited by 359

Long-Acting Injectable Risperidone for Relapse Prevention and Control of Breakthrough Symptoms After a Recent First Episode of Schizophrenia: A Randomized Clinical Trial

Subotnik, K. L., Casaus, L. R., Ventura, J., Luo, J. S., Hellemann, G. S., Gretchen-Doorly, D., Marder, S., & Nuechterlein, K. H. (2015) · JAMA Psychiatry

Schizophrenia research and treatmentFamily Caregiving in Mental Illness

Cited by 262

The MCCB impairment profile for schizophrenia outpatients: results from the MATRICS psychometric and standardization study

Kern, R. S., Gold, J. M., Dickinson, D., Green, M. F., Nuechterlein, K. H., Baade, L. E., Keefe, R. S. E., Mesholam-Gately, R. I., Seidman, L. J., Lee, C., et al. (2011) · Schizophrenia Research

Schizophrenia research and treatmentPsychological Testing and Assessment

Cited by 251

Schizophrenia--Time to Commit to Policy Change

Fleischhacker, W. W., Arango, C., Arteel, P., Barnes, T. R. E., Carpenter, W., Duckworth, K., Galderisi, S., Halpern, L., Knapp, M., Marder, S. R., et al. (2014) · Schizophrenia Bulletin

Schizophrenia research and treatmentPsychiatric care and mental health services

Cited by 214

A randomized clinical trial of MK-0777 for the treatment of cognitive impairments in people with schizophrenia

Buchanan, R. W., Keefe, R. S. E., Lieberman, J. A., Barch, D. M., Csernansky, J. G., Goff, D. C., Gold, J. M., Green, M. F., Jarskog, L. F., Javitt, D. C., et al. (2011) · Biological Psychiatry

Schizophrenia research and treatmentNeurotransmitter Receptor Influence on Behavior

Cited by 172

Evaluation of functionally meaningful measures for clinical trials of cognition enhancement in schizophrenia

Green, M. F., Schooler, N. R., Kern, R. S., Frese, F. J., Granberry, W., Harvey, P. D., Karson, C. N., Peters, N., Stewart, M., Seidman, L. J., et al. (2011) · American Journal of Psychiatry

Schizophrenia research and treatmentPsychological Testing and Assessment

Cited by 159

Oxytocin-Augmented Social Cognitive Skills Training in Schizophrenia

Davis, M. C., Green, M. F., Lee, J., Horan, W. P., Senturk, D., Clarke, A. D., & Marder, S. R. (2014) · Neuropsychopharmacology

Schizophrenia research and treatmentNeuroendocrine regulation and behavior

Cited by 149

Clinical trials of potential cognitive-enhancing drugs in schizophrenia: what have we learned so far?

Keefe, R. S. E., Buchanan, R. W., Marder, S. R., Schooler, N. R., Dugar, A., Zivkov, M., & Stewart, M. (2013) · Schizophrenia Bulletin

Schizophrenia research and treatmentNeurotransmitter Receptor Influence on Behavior

Cited by 138

Effects of single dose intranasal oxytocin on social cognition in schizophrenia

Davis, M. C., Lee, J., Horan, W. P., Clarke, A. D., McGee, M. R., Green, M. F., & Marder, S. R. (2013) · Schizophrenia Research

Schizophrenia research and treatmentNeuroendocrine regulation and behavior

Cited by 124

History of Psychopharmacology

Braslow, J. T., & Marder, S. R. (2019) · Annual Review of Clinical Psychology

Historical Psychiatry and Medical PracticesHistorical Medical Research and Treatments

Cited by 122

The psychopathology, medical management and dental implications of schizophrenia

FRIEDLANDER, A. H., & MARDER, S. R. (2002) · The Journal of the American Dental Association

Schizophrenia research and treatmentDental Health and Care Utilization

Cited by 115

Selective corticostriatal dysfunction in schizophrenia: examination of motor and cognitive skill learning

Foerde, K., Poldrack, R. A., Knowlton, B. J., Sabb, F. W., Bookheimer, S. Y., Bilder, R. M., Guthrie, D., Granholm, E., Nuechterlein, K. H., Marder, S. R., et al. (2008) · Neuropsychology

Schizophrenia research and treatmentMotor Control and Adaptation

Cited by 67

Dual-task performance operating characteristics, resource limitations, and automatic processing in schizophrenia.

Granholm, E., Asarnow, R. F., & Marder, S. R. (1996) · Neuropsychology

Schizophrenia research and treatmentNeural and Behavioral Psychology Studies

Cited by 59

Bipolar I disorder

FRIEDLANDER, A. H., FRIEDLANDER, I. K., & MARDER, S. R. (2002) · The Journal of the American Dental Association

Bipolar Disorder and TreatmentOral Health Pathology and Treatment

Cited by 41

Parsing components of auditory predictive coding in schizophrenia using a roving standard mismatch negativity paradigm

McCleery, A., Mathalon, D. H., Wynn, J. K., Roach, B. J., Hellemann, G. S., Marder, S. R., & Green, M. F. (2019) · Psychological Medicine

Schizophrenia research and treatmentNeuroscience and Music Perception

Cited by 35

Advancing drug discovery for schizophrenia

Marder, S. R., Roth, B., Sullivan, P. F., Scolnick, E. M., Nestler, E. J., Geyer, M. A., Welnberger, D. R., Karayiorgou, M., Guidotti, A., Gingrich, J., et al. (2011) · Annals of the New York Academy of Sciences

Schizophrenia research and treatmentNeurotransmitter Receptor Influence on Behavior

Cited by 25